Literature DB >> 3304182

Biological properties and mode of action of clavams.

F Röhl, J Rabenhorst, H Zähner.   

Abstract

The clavams valclavam and hydroxyethylclavam were both bacteriostatic and fungistatic. The molecular basis for growth inhibition of Escherichia coli was a non-competitive inhibition of homoserine-O-succinyltransferase (EC 2.3.1.46), thus blocking methionine biosynthesis. Eucaryotes such as Saccharomyces cerevisiae were inhibited by a different mode of action. Instead of interfering with methionine biosynthesis, the clavams inhibited the formation of RNA in living cells, although the RNA-polymerases of isolated yeast nuclei were not inhibited. The action of valclavam on E. coli was dependent on functional peptide transport systems.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304182     DOI: 10.1007/BF00406126

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  16 in total

Review 1.  The isolation of yeast nuclei and methods to study their properties.

Authors:  J H Duffus
Journal:  Methods Cell Biol       Date:  1975       Impact factor: 1.441

2.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

3.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

Review 4.  Genetic analysis and genome structure in Streptomyces coelicolor.

Authors:  D A Hopwood
Journal:  Bacteriol Rev       Date:  1967-12

5.  Multimetabolite control of a biosynthetic pathway by sequential metabolites.

Authors:  L W Lee; J M Ravel; W Shive
Journal:  J Biol Chem       Date:  1966-11-25       Impact factor: 5.157

6.  [Isolation conditions for cell nuclei from yeast protoplasts].

Authors:  R May
Journal:  Z Allg Mikrobiol       Date:  1971

7.  Sensitivity to nikkomycin Z in Candida albicans: role of peptide permeases.

Authors:  J C Yadan; M Gonneau; P Sarthou; F Le Goffic
Journal:  J Bacteriol       Date:  1984-12       Impact factor: 3.490

8.  Clavamycins, new clavam antibiotics from two variants of Streptomyces hygroscopicus. I. Taxonomy of the producing organisms, fermentation, and biological activities.

Authors:  H D King; J Langhärig; J J Sanglier
Journal:  J Antibiot (Tokyo)       Date:  1986-04       Impact factor: 2.649

9.  Mechanism of action of nikkomycin and the peptide transport system of Candida albicans.

Authors:  P J McCarthy; P F Troke; K Gull
Journal:  J Gen Microbiol       Date:  1985-04

10.  Leptomycins A and B, new antifungal antibiotics. III. Mode of action of leptomycin B on Schizosaccharomyces pombe.

Authors:  T Hamamoto; T Uozumi; T Beppu
Journal:  J Antibiot (Tokyo)       Date:  1985-11       Impact factor: 2.649

View more
  2 in total

1.  Methionine Limitation Impairs Pathogen Expansion and Biofilm Formation Capacity.

Authors:  A Jochim; T Shi; D Belikova; S Schwarz; A Peschel; S Heilbronner
Journal:  Appl Environ Microbiol       Date:  2019-04-18       Impact factor: 4.792

Review 2.  Biosynthesis of clavam metabolites.

Authors:  Susan E Jensen
Journal:  J Ind Microbiol Biotechnol       Date:  2012-09-05       Impact factor: 3.346

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.